Friday - December 27, 2024

Heavy Peptide Approach to Accurately Measure Unprocessed C-Terminal Lysine

2024-10-22

ALEXANDRIA, Virginia, Oct. 22 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12123879 B2, initially filed June 18, 2021) developed by five inventors Tyler Greer, Elmsford, New York; Milos Cejkov, Ridgewood, New Jersey; Reid O'Brien Johnson, Hartsdale, New York; Xiaojing Zheng, Croton-on-the-Hudson, New York; and Ning Li, New Canaan, Connecticut, for "Heavy peptide approach to accurately measure unprocessed C-terminal lysine." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Heavy Peptide Approach to Accurately Measure Unprocessed C-Terminal Lysine

Information Request Form

Copyright Targeted News Service 2024